OrthoPediatrics Corp. $KIDS Stake Increased by Harbor Capital Advisors Inc.

Key Points

• Harbor Capital Advisors Inc. has increased its stake in OrthoPediatrics Corp. by 116.5%, owning a total of 333,959 shares valued at approximately $7.17 million as of the latest SEC disclosure.
• Analyst ratings for OrthoPediatrics reflect positive sentiment, with seven analysts giving a Buy rating and a consensus price target set at $34.14.
• Insider trading activity includes CFO Fred Hite purchasing 5,076 shares at an average price of $19.41 per share, increasing his holdings to a total value of approximately $4.14 million.

Harbor Capital Advisors Inc. raised its holdings in OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 116.5% in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 333,959 shares of the company's stock after acquiring an additional 179,733 shares during the period. Harbor Capital Advisors Inc. owned 1.38% of OrthoPediatrics worth $7,173,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the business. Northern Trust Corp lifted its position in OrthoPediatrics by 0.3% during the fourth quarter. Northern Trust Corp now owns 193,798 shares of the company's stock worth $4,492,000 after buying an additional 644 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of OrthoPediatrics by 6.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,995 shares of the company's stock valued at $246,000 after acquiring an additional 645 shares during the period. Invesco Ltd. lifted its stake in shares of OrthoPediatrics by 12.1% during the first quarter. Invesco Ltd. now owns 18,349 shares of the company's stock worth $452,000 after purchasing an additional 1,986 shares in the last quarter. American Century Companies Inc. grew its holdings in OrthoPediatrics by 16.1% during the 1st quarter. American Century Companies Inc. now owns 30,658 shares of the company's stock valued at $755,000 after purchasing an additional 4,248 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. increased its position in shares of OrthoPediatrics by 46.8% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 14,148 shares of the company's stock worth $348,000 after acquiring an additional 4,508 shares during the last quarter. Institutional investors and hedge funds own 69.05% of the company's stock.

Insider Buying and Selling

In related news, CFO Fred Hite purchased 5,076 shares of the company's stock in a transaction on Thursday, August 21st. The shares were bought at an average cost of $19.41 per share, for a total transaction of $98,525.16. Following the transaction, the chief financial officer owned 213,065 shares of the company's stock, valued at $4,135,591.65. This represents a 2.44% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Insiders own 32.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on KIDS. BTIG Research dropped their price target on shares of OrthoPediatrics from $40.00 to $39.00 and set a "buy" rating for the company in a research note on Wednesday, August 6th. Citigroup reissued a "market outperform" rating on shares of OrthoPediatrics in a research report on Friday, August 8th. JMP Securities set a $35.00 price target on OrthoPediatrics and gave the stock a "market outperform" rating in a research note on Friday, August 8th. Finally, Wall Street Zen upgraded OrthoPediatrics from a "sell" rating to a "hold" rating in a research note on Saturday, August 9th. Seven analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, OrthoPediatrics presently has a consensus rating of "Moderate Buy" and an average price target of $34.14.

OrthoPediatrics Stock Performance

KIDS stock traded down $0.93 during mid-day trading on Friday, reaching $19.18. The company had a trading volume of 223,650 shares, compared to its average volume of 136,948. OrthoPediatrics Corp. has a one year low of $16.59 and a one year high of $32.00. The stock has a market capitalization of $480.84 million, a P/E ratio of -10.72 and a beta of 1.06. The company has a quick ratio of 3.43, a current ratio of 6.66 and a debt-to-equity ratio of 0.27. The stock's 50-day simple moving average is $20.66 and its two-hundred day simple moving average is $21.76.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.17) by $0.06. OrthoPediatrics had a negative return on equity of 6.36% and a negative net margin of 18.92%.The business had revenue of $61.08 million during the quarter, compared to the consensus estimate of $61.40 million. OrthoPediatrics has set its FY 2025 guidance at EPS. Research analysts anticipate that OrthoPediatrics Corp. will post -0.93 EPS for the current year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.